Ask An Expert: What happens if you miss your second dose of the COVID-19 vaccine?
Excerpts and edited notes for this blog were referenced from an “Ask An Expert” KCBS radio station 740 FM segment on December 22nd, 2020 at 9:20 AM hosted by Stan Bunger. The following information was prepared by Jessica Yi. This blog is presented for viewers to validate, accept and/or decline its content and findings on their own.
Ask An ExpertAt least 70,000 Californians have already received their first doses of Pfizer’s COVID-19 vaccine, and Moderna has also begun shipping out its vaccine this week.
Both vaccines will require patients to return for a second shot within a few weeks of getting the first dose. Pfizer advises patients to get the second dose in 21 days, and Moderna after 28 days. Getting the second shot increases the vaccine’s effectiveness and may also prolong immunity.
In the case of the Pfizer vaccine, efficacy increased from around 50% to 95% after study participants got the second dose.
“Ideally you want to get that second shot in that timeframe because that’s what’s been studied,” explained Dr. Roshni Mathew, Stanford Pediatrician and Infectious Disease Physician on KCBS Radio’s “Ask An Expert” early Tuesday.
However, the logistical challenges of getting patients to return in exactly 21 or 28 days for another dose of the vaccine will be significant, especially with the current levels of demand.
But Dr. Mathew said even if you do not get the second shot within the exact window, “that’s fine, you should just move forward…the CDC says that if you do get delayed for some reason and you have to get the second shot way further down than that specific time limit, you should go ahead and get that second shot, no need to repeat.”
The current guidance is based on the methodology that was studied and has therefore been proven, but vaccine experts have said there is no reason to think the second dose won’t be effective if it is not received in a narrow window of time.
Some of the other vaccine candidates that are still undergoing trials may not require two doses, such as the Johnson & Johnson vaccine.